Episode 101: In the Clinic - The future of Adjuvant treatment in kidney cancer with Dr Will Ince and Dr Naveen Vasudev
Simply OncologyShow Notes
Send us Fan Mail Join us as we complete our tour of the adjuvant kidney cancer treatment space. We are joined again by the excellent Dr Will Ince from Cambridge and Dr Naveen Vasudev from Leeds! In our last episode we discussed KEYNOTE 564 and the RAMPART study and where this places immunotherapy in adjuvant kidney cancer. In this episode we discuss the LITESPARK 022 trial and the addition of Belzutifan to Pembrolizumab in adjuvant kidney cancer treatment. We also discuss the potential for KI...
More from Simply Oncology
Send us Fan Mail Join us today for an amazing round up of the peri-operative space in colon cancer with the excellent Professor Jenny Seligmann from Leeds. We discuss all aspects of the FOXTROT trials and where this peri-operative space. With the AZURE trial reporting this weekend at ESMO we discuss the landscape in peri-operative management.
Send us Fan Mail 🎙️Join us as we finish our discussion through Kidney Cancer with the wonderful Professor Daniel Heng of Calgary,Canada🇨🇦 🎙️In this episode we focus on the Real World Evidence 🌎🔎 from the IMDC 🎙️what cane we learn from comparing complete response rates and durable responses between IO-IO therapy and IO-VEGF therapy🤔 🎙️What has Danny learned through setting up the IMDC and how to bring people with you? 🎙️What areas does Danny think need expanding in the future in Renal Cancer? ...
Send us Fan Mail 🚨Join us today as we discuss all things kidney cancer !! 💥We are Hanging with the Heng! The legend that is Professor Daniel Heng (AKA DannyHeng tm) from The Albert Child Cancer Centre, Calgary, Canada🇨🇦 🎙️We hear how Danny Heng started the IMDC (International Metastatic renal cell carcinoma Database Consortium) prognostic score in advanced kidney cancer. 🎙️We discuss how the IMDC moved as prognostic score to then being part of stratification for modern metastatic kidne...
Send us Fan Mail Join us as we complete our discussion on all things Acute Oncology Services with the superb Dr Caroline Wilson PhD FRCP from the The Christie NHS Foundation Trust. 🎙️We look at what future directions AOS will move into and what the challenges may be. 🎙️What are the BIG 5 AOS presentations? 🎙️Caroline stakes a claim for the need to change how we view the role of who manages acute oncology toxicities. Enjoy
Send us Fan Mail Welcome back - today we are discussing Acute Oncology Services and how they have evolved over the last 15 years. Why were they set up ? To give cancer patients support and care when they need it most - when they are admitted to hospital with problems. Do you know your type 1 from your type 2 or 3 Acute oncology patient? We talk all things AOS with the wonderful Dr Caroline Wilson from The Christie Hospital in Manchester. What would your ideal Acute Oncology Service look...